The Transformative Impact of the OBBBA on R&E Tax Strategies

Research and Experimental (R&E) expenditures play a vital role in driving innovation and technological advancement across various sectors. These costs have historically been incentivized through tax deductions, reducing taxable income and encouraging further investment in innovation.

The One Big Beautiful Bill Act (OBBBA), enacted on July 4, 2025, has reintroduced the immediate deduction of domestic R&E expenditures, counteracting the prior constraints set by the Tax Cuts and Jobs Act (TCJA) of 2017. Under the newly established IRC Section 174A, the Act revives a crucial incentive for U.S.-based research, although it maintains stringent capitalization rules for foreign R&E activities.Image 3

Understanding R&E Costs R&E, also known as research and development (R&D) expenses, include costs associated with developing or improving products, such as software development. Typically, these costs encompass:

  • Wages for research personnel.

  • Expenditures on materials and supplies used in research.

  • Outsourcing costs for external research services.

  • Related overheads, including rent, utilities, and maintenance for R&E facilities and equipment.

Image 2

A Brief History of R&E Expensing Prior to the TCJA amendments effective for tax years post-December 31, 2021, businesses could either immediately deduct R&E costs or amortize them over a minimum of 60 months under the former Section 174. This flexibility was particularly beneficial for innovation-driven companies in terms of cash flow.

The TCJA mandate, starting 2022, required the capitalization and amortization of all R&E expenses over five years domestically and 15 years for international research. This change imposed significant cash tax burdens, especially affecting early-stage entities that incurred substantial R&D outlays without immediate revenue, as deductions were spread over several years.

Post-OBBBA R&E Expensing Effective for fiscal years beginning beyond December 31, 2024, the OBBBA through Section 174A radically transforms the framework for U.S.-based R&E activities.

Domestic versus International Perspectives The OBBBA distinctly emphasizes the location of research activities:

  • Domestic R&E Expenditures: Businesses can now permanently deduct 100% of these costs immediately upon payment or incurrence, rekindling pre-2022 tax advantages and incentivizing domestic research initiatives. Companies can opt to capitalize and amortize these costs over at least 60 months if preferred.

  • International R&E Expenditures: The existing 15-year amortization guideline persists for non-U.S. research under the OBBBA. Immediate recovery of unamortized amounts upon the disposal or abandonment post-May 12, 2025, is not permitted, potentially prompting multinational entities to reconsider their research locales to optimize tax benefits.

Options for Accelerated R&E Expensing The OBBBA provides important transitional relief for R&E expenditures capitalized from 2022-2024 as per previous TCJA mandates. Taxplayers can accelerate deductions starting in the first tax year after December 31, 2024, typically the 2025 tax year:

  • Option 1: Immediate Expensing in 2025: Deduct all remaining unamortized domestic R&E amounts in the first fiscal year post-2024.

  • Option 2: Two-Year Amortization: Distribute the unamortized balance over two years — 50% in 2025 and 50% in 2026.

  • Option 3: Continue Amortization: Continue the amortization over the original five-year timeline.

  • For Qualified Small Businesses: Businesses with average annual gross receipts of $31 million or less over the preceding three tax years may apply the full expensing retroactively to tax years beginning after December 31, 2021, by filing amended returns for 2022, 2023, and 2024 to claim refunds. This election, requiring adjustments to the R&D tax credit (Section 280C(c)), must be completed by July 4, 2026.

Image 1

Integration with Other Tax Policies The revised R&E expensing guidelines significantly impact other tax code facets, including the net operating loss (NOL), bonus depreciation, business interest expense limitation, and international taxation for sizeable organizations. Comprehensive strategizing, incorporating these tax provisions, can notably lower tax liabilities, fostering potential planning avenues for taxpayers.

Accounting Method Adaptations These transitional policies represent an automatic accounting method change, streamlining compliance. The opportunity to "catch up" on deductions presents a substantial cash flow boost for affected companies, mitigating previous capitalization demands. The IRS has provided preliminary guidance through Rev Proc 2025-28 on transitioning by attaching a statement to tax returns as opposed to filing Form 3115.

Contact our office to customize modeling of your options and identify the best strategies for your circumstances, considering impacts on other tax aspects like Net Operating Loss (NOL) rules and business interest limitations.

Share this article...

Want tax & accounting tips and insights?

Sign up for our newsletter.

I confirm this is a service inquiry and not an advertising message or solicitation. By clicking “Submit”, I acknowledge and agree to the creation of an account and to the and .